This has been an epically bad year for the healthcare sector, but there are still a few stocks out there that Wall Street analysts like. Some of them are even more beaten down than the rest of the industry.
Still, opportunities for stock picking remain. A few individual health stocks have far outperformed the market this year, including Eli Lilly , Vertex Pharmaceuticals , and Zoetis . Other stocks that passed the screen are smaller, and less well-known. They are DexCom , which sells a glucose monitoring system for diabetes patients; Bio-Techne , which sells tools to the life sciences industry; and Bio-Rad Laboratories , which also services the life science research and diagnostics industries.
Nederland Laatste Nieuws, Nederland Headlines
Similar News:Je kunt ook nieuwsberichten lezen die vergelijkbaar zijn met deze die we uit andere nieuwsbronnen hebben verzameld.
Bron: CNBC - 🏆 12. / 72 Lees verder »